Fiasp 100 Unit

FIASP 100 Unit insulin aspart solution is a fast-acting insulin used for managing blood glucose levels in diabetes. This subcutaneous injection, manufactured by Novo Nordisk Canada Inc., is designed for precise glucose control.

FIASP insulin aspart is primarily used for the management of diabetes, helping to control blood sugar levels. It is often administered before meals to address rapid insulin needs. This fast-acting insulin is suitable for both type 1 and type 2 diabetes, aiding in the regulation of glucose levels throughout the day.

FIASP insulin aspart works quickly to lower blood sugar levels after meals. Users may experience improved glucose control, but individual responses can vary. Common effects include rapid onset and short duration of action, making it ideal for meal-time insulin needs.

FIASP insulin aspart should be handled with care, ensuring proper storage and administration. It is important to follow healthcare provider instructions for use. Monitor blood sugar levels regularly and be aware of potential hypoglycemia, especially when adjusting doses or changing insulin types.

FIASP insulin aspart may interact with other medications, including oral hypoglycemic agents and certain antihypertensive drugs. Alcohol and other substances that affect blood sugar levels should be used cautiously. Always consult a healthcare provider before combining FIASP with other treatments.